| Note: this medical device has supplements. The device description may have changed. Be sure to look at the supplements to get an up-to-date view of this device. |
| |
| Trade Name | ABBOTT ARCHITECT AUSAB |
| Classification Name | test, hepatitis b (b core, be antigen, be antibody, b core igm) |
| Applicant | ABBOTT LABORATORIES INC |
| PMA Number | P050051 |
| Date Received | 12/09/2005 |
| Decision Date | 06/01/2006 |
| Product Code | |
| Docket Number | 06M-0321 |
| Notice Date | 08/17/2006 |
| Advisory Committee |
Microbiology |
| Expedited Review Granted? | No |
| Combination Product |
No
|
| Information About: |
Labeling, Approval Order, Summary of Safety and Effectiveness |
Approval Order Statement Approval for the architect ausab reagent kit, which is indicated for: architect ausab reagent kit: the architect ausab assay is a chemiluminescent microparticle immunoassay (cmia) for the quantitative determination of antibody to hepatitis b surface antigen (anti-hbs) in human adult and pediatric serum and plasma (dipotassium edta, lithium heparin, and sodium heparin) and neonatal serum. It is intended for quantitative measurement of antibody response following hepatitis b virus (hbv) vaccination, determination of hbv immune status, and for the laboratory diagnosis of hbv disease associated with hbv infection when used in conjunction with other laboratory results and clinical information. Architect ausab calibrators: the architect ausab calibrators are used to calibrate the architect i system when the system is used for the quantitative determination of antibody to hepatitis b surface antigen (anti-hbs) using the architect ausab reagent kit. The performance of the architect ausab calibrators has not been established with any other anti- hbs assays. Architect ausab controls: the architect ausab controls are used for monitoring the performance of the architect i system when used for the quantitative determination of antibody to hepatitis b surface antigen (anti-hbs) using the architect ausab reagent kit. The performance of the architect ausab controls has not been established with any other anti-hbs assays. |
| Approval Order |
Approval Order
|
| Supplements: |
S001 S002 S003 S004 S005 S006 S007 S008 S009 S010 S011 S012 S013 S014 S015 S016 S017 S018 S019 S020 |
|
|